Protalix BioTherapeutics, Inc.
AMEX:PLX
1.4 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 65.494 | 47.638 | 38.35 | 62.898 | 54.693 | 34.24 | 19.242 | 9.199 | 4.364 | 15.16 | 11.513 | 34.424 | 8.386 | 6.642 | 0.388 | 0 | 0 | 0.15 | 0 | 0 | 0 | 0 | 0 | 0 | 3.555 | 8.036 | 0 | 0 |
| Cost of Revenue
| 22.982 | 19.592 | 16.349 | 10.873 | 10.895 | 9.302 | 15.231 | 8.398 | 0.73 | 9.053 | 5.428 | 8.144 | 6.943 | 8.985 | 3.575 | 0 | 0 | 0.035 | 0 | 0 | 0 | 0 | 0 | 0 | 2.684 | 6.306 | 0 | 0 |
| Gross Profit
| 42.512 | 28.046 | 22.001 | 52.025 | 43.798 | 24.938 | 4.011 | 0.801 | 3.634 | 6.107 | 6.085 | 26.28 | 1.443 | -2.343 | -3.187 | 0 | 0 | 0.115 | 0 | 0 | 0 | 0 | 0 | 0 | 0.871 | 1.73 | 0 | 0 |
| Gross Profit Ratio
| 0.649 | 0.589 | 0.574 | 0.827 | 0.801 | 0.728 | 0.208 | 0.087 | 0.833 | 0.403 | 0.529 | 0.763 | 0.172 | -0.353 | -8.214 | 0 | 0 | 0.767 | 0 | 0 | 0 | 0 | 0 | 1 | 0.245 | 0.215 | 0 | 0 |
| Reseach & Development Expenses
| 17.093 | 29.349 | 29.734 | 38.167 | 44.616 | 33.33 | 28.834 | 24.608 | 20.025 | 21.65 | 24.816 | 28.689 | 31.043 | 29.951 | 21.638 | 17.401 | 12.861 | 5.246 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| -25.459 | -13.581 | -4.02 | -5.088 | -5.967 | 1.938 | 0 | 0 | 0 | 0 | 8.385 | 9.763 | 6.931 | 6.876 | 7.144 | 6.77 | 11.706 | 2.131 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 40.418 | 25.292 | 16.749 | 16.236 | 15.866 | 8.978 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.394 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.959 | 11.711 | 12.729 | 11.148 | 9.899 | 10.916 | 11.53 | 9.356 | 7.279 | 9.661 | 8.385 | 9.763 | 6.931 | 6.876 | 7.144 | 6.77 | 11.706 | 4.525 | 0.093 | 0.166 | 0.147 | 0.166 | 0.292 | 0.382 | 1.524 | 2.086 | 0.164 | 0.044 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.094 | 0 | 0.163 | 0.818 | 0 | 0 |
| Operating Expenses
| 32.052 | 41.06 | 42.463 | 49.315 | 54.515 | 44.246 | 40.364 | 33.964 | 27.304 | 31.311 | 33.201 | 38.452 | 37.974 | 36.827 | 28.782 | 24.171 | 24.567 | 9.771 | 0.093 | 0.166 | 0.147 | 0.166 | 0.386 | 0.382 | 1.687 | 2.904 | 0.164 | 0.044 |
| Operating Income
| 10.46 | -13.014 | -20.462 | 1.846 | -10.717 | -19.308 | -36.353 | -33.163 | -23.67 | -25.204 | -27.116 | -12.172 | -36.531 | -29.966 | -31.969 | -24.171 | -24.567 | -9.771 | -0.093 | -0.166 | -0.147 | -0.166 | -0.386 | -0.382 | -0.816 | -1.174 | -0.164 | -0.044 |
| Operating Income Ratio
| 0.16 | -0.273 | -0.534 | 0.029 | -0.196 | -0.564 | -1.889 | -3.605 | -5.424 | -1.663 | -2.355 | -0.354 | -4.356 | -4.512 | -82.394 | 0 | 0 | -65.14 | 0 | 0 | 0 | 0 | 0 | -381,851 | -0.23 | -0.146 | 0 | 0 |
| Total Other Income Expenses Net
| -1.894 | -1.383 | -7.12 | -8.369 | -7.559 | -7.149 | -39.386 | 14.063 | -3.612 | -4.739 | -0.674 | 0.554 | 43.308 | 58.964 | 63.409 | 46.585 | 0.006 | 11.535 | 0.004 | 0 | 0 | 0 | -0.094 | 0.15 | -0.254 | 0 | 0.344 | 0.244 |
| Income Before Tax
| 8.566 | -14.397 | -27.582 | -6.523 | -18.276 | -26.457 | -85.276 | -29.176 | -27.282 | -29.943 | -27.79 | -11.618 | 0.002 | 28.998 | 31.44 | 22.414 | -2.08 | 5.746 | -0.089 | 0 | 0 | -0.165 | -0.48 | -0.232 | -1.071 | 0 | 0.179 | 0.2 |
| Income Before Tax Ratio
| 0.131 | -0.302 | -0.719 | -0.104 | -0.334 | -0.773 | -4.432 | -3.172 | -6.252 | -1.975 | -2.414 | -0.337 | 0 | 4.366 | 81.031 | 0 | 0 | 38.307 | 0 | 0 | 0 | 0 | 0 | -231,621 | -0.301 | 0 | 0 | 0 |
| Income Tax Expense
| 0.254 | 0.53 | 6.403 | 8.369 | 7.966 | 0.536 | 7.805 | 10.854 | -87.566 | -2.944 | 0 | 0 | 43.306 | 48.792 | 62.88 | 44.828 | -2.086 | 11.154 | -0.014 | 0.16 | 0.141 | -0.016 | -0.151 | -0.126 | 0.182 | -0.027 | 0.061 | 0.068 |
| Net Income
| 8.312 | -14.927 | -33.985 | -14.892 | -26.242 | -26.457 | -85.276 | -29.365 | 58.037 | -29.943 | -27.79 | -11.618 | -36.529 | -28.998 | -31.44 | -22.414 | -22.481 | -9.39 | -0.075 | -0.16 | -0.141 | -0.15 | -0.329 | -0.106 | -0.998 | -1.147 | 0.118 | 0.132 |
| Net Income Ratio
| 0.127 | -0.313 | -0.886 | -0.237 | -0.48 | -0.773 | -4.432 | -3.192 | 13.299 | -1.975 | -2.414 | -0.337 | -4.356 | -4.366 | -81.031 | 0 | 0 | -62.6 | 0 | 0 | 0 | 0 | 0 | -105,609 | -0.281 | -0.143 | 0 | 0 |
| EPS
| 0.12 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 | -0.3 | -0.13 | -0.43 | -0.36 | -0.41 | -0.3 | -3.35 | -0.32 | -0.004 | -0.009 | -0.48 | -0.51 | -1.02 | -0.26 | -1.91 | -2.51 | 0.47 | 0.61 |
| EPS Diluted
| 0.087 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 | -0.3 | -0.13 | -0.43 | -0.36 | -0.41 | -0.3 | -3.35 | -0.32 | -0.004 | -0.009 | -0.48 | -0.51 | -1.02 | -0.26 | -1.91 | -2.51 | 0.47 | 0.61 |
| EBITDA
| 11.651 | -10.782 | -20.061 | 3.148 | -8.693 | -18.772 | -36.165 | -30.591 | -23.547 | -25.008 | -23.577 | -8.48 | -32.9 | -36.037 | -29.979 | -22.87 | -23.814 | -9.269 | -0.098 | -0.166 | -0.147 | -0.166 | -0.292 | -0.532 | -0.399 | -0.972 | -0.164 | -0.044 |
| EBITDA Ratio
| 0.178 | -0.226 | -0.523 | 0.05 | -0.159 | -0.548 | -1.879 | -3.325 | -5.396 | -1.65 | -2.048 | -0.246 | -3.923 | -5.426 | -77.265 | 0 | 0 | -61.793 | 0 | 0 | 0 | 0 | 0 | -532,081 | -0.112 | -0.121 | 0 | 0 |